Kaloderm? is an allogeneic epidermal cell sheet for healing wounds. It is cultured keratinocytes originated from the foreskin of a circumcised infant. We have the technology to propagate the cells almost indefinitely, meaning that Kaloderm? will always be made from the single source and maintain the same quality. Kaloderm? is mass-produced on a regular basis and can be stored frozen at -60¡ÆC for 24 months. Since the 2005 KFDA approval, 250,000 sheets have been used, mostly in burn clinics. We continue to upgrade its efficacy and expanding its applications.

* Summary Characteristics
-A cell therapy drug composed of cultured human keratinocytes and indicated to treat deep 2nd degree burns and diabetic foot ulcers.
-The source cells derived from a Korean infant in 2001.
-Heals 40% faster than conventional dressing and minimizes scar formation.